Marsh & McLennan Companies, Inc.
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Marsh & McLennan Companies, Inc..
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Price history
Chart
Interactive price chart (TradingView).
52-week range: 157.30 $ to 207.00 $ · Last price: 174.60 $ (As of: September 17, 2026)
Key figures
Key figures at a glance
Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 09/18/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Comparison
Industry comparison
The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.
Industry: Insurance Brokers
| Company | Market cap ($B) | P/E | EV/EBITDA | Gross Margin % | EBIT Margin % | Sales Growth (Year) % | Perf. 1Y % |
|---|---|---|---|---|---|---|---|
| Marsh & McLennan Companies, Inc. MRSH | 84.8 | 22.6 | 14.6 | 44.0 | 24.3 | 10.3 | -9.7 |
| Aon PLC AON | 63.2 | 17.1 | 11.7 | 48.2 | 35.8 | 9.5 | -16.5 |
| Arthur J Gallagher & Co AJG | 62.0 | 41.2 | 18.7 | 43.2 | 28.4 | 20.7 | -15.4 |
| Willis Towers Watson PLC WTW | 29.4 | 18.7 | 13.1 | 42.5 | 20.5 | -2.2 | -5.3 |
| Brown & Brown Inc BRO | 22.1 | 22.8 | 12.1 | 56.3 | 47.2 | 26.6 | -28.7 |
| Erie Indemnity Company ERIE | 12.8 | 22.2 | 0.0 | 17.9 | 19.1 | 7.2 | -21.8 |
| Accelerant Holdings ARX | 4.3 | – | 0.0 | 65.1 | -2.2 | 47.2 | 17.1 |
| Neptune Insurance Holdings Inc. NP | 4.1 | 143.7 | 58.6 | 52.7 | 47.5 | 33.7 | – |
| CorVel Corp CRVL | 3.6 | 34.1 | 18.5 | 24.8 | 16.0 | 7.0 | -13.6 |
| Median of companies shown | 22.1 | 22.7 | 13.1 | 44.0 | 24.3 | 10.3 | -14.5 |
Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →
Fiscal years
Annual Figures
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
Revenue, operating income and net income per fiscal year $M
Revenue Operating income Net income
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 13,211 | 2,431 | 1,768 | 3.37 | 2,007 | 6,192 | 18,190 |
| 2017 | 14,024 | 2,655 | 1,492 | 2.87 | 1,893 | 7,359 | 20,429 |
| 2018 | 14,950 | 2,761 | 1,650 | 3.23 | 2,428 | 7,511 | 21,578 |
| 2019 | 16,652 | 2,677 | 1,742 | 3.41 | 2,361 | 7,793 | 31,317 |
| 2020 | 17,224 | 3,066 | 2,016 | 3.94 | 3,382 | 9,104 | 33,030 |
| 2021 | 19,820 | 4,312 | 3,143 | 6.13 | 3,516 | 11,009 | 34,388 |
| 2022 | 20,720 | 4,280 | 3,050 | 6.04 | 3,465 | 10,520 | 44,114 |
| 2023 | 22,736 | 5,282 | 3,756 | 7.53 | 4,258 | 12,191 | 48,030 |
| 2024 | 24,458 | 5,817 | 4,060 | 8.19 | 4,302 | 13,342 | 56,481 |
| 2025 | 26,981 | 6,223 | 4,160 | 8.49 | 5,292 | 15,100 | 58,710 |
Quarters
Quarterly Figures
Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 1.59 | 4.70 | 6,067 | 9.20 | 13.00 | 1,956 | 1,880 |
| 2025: Q1 | 2.79 | -1.00 | 7,061 | 9.10 | 19.60 | -622 | -677 |
| 2025: Q2 | 2.45 | 7.90 | 6,974 | 12.10 | 17.40 | 1,671 | 1,612 |
| 2025: Q3 | 1.51 | 0.40 | 6,351 | 11.50 | 11.80 | 2,082 | 2,010 |
| 2025: Q4 | 1.68 | 5.50 | 6,595 | 8.70 | 12.40 | 2,161 | 2,056 |
| 2026: Q1 | 2.36 | -15.50 | 7,597 | 7.60 | 15.10 | -688 | -750 |
| 2026: Q2 | 2.63 | 7.30 | 7,404 | 6.20 | 17.10 | 1,523 | 1,451 |
What Do These Terms Mean?
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Screening
Appears in These Scanners
This stock currently matches 2 of our scanner strategies — each hit links to the scanner.
Aktien.Guide
Dividends
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Outlook
Analysts & Price Target
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Distribution of Recommendations
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 10.45 | 10.30 – 10.54 | 28,560 | 7.2% | 23 |
| 12/31/2027 | 11.41 | 10.90 – 11.62 | 29,948 | 9.2% | 23 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Valuation
What is priced in?
Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.
Today’s market value implies roughly 6.1% growth in free cash flow per year over ten years (assumptions: discount rate 10.0%, terminal growth 2.5%).
| Free cash flow (last twelve months) | $4.77B |
|---|---|
| Market cap | $84.75B |
| Free cash flow in year ten | $8.62B |
| Terminal value as a share of market value | 53.6% |
For comparison: over the past five years free cash flow grew by 10.5% per year.
It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.
A simplified model calculation — not a forecast and not a recommendation.
AI classification
AI Rating
Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available.
Growth
Growth Score
Ten checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 9.2%
- More than 10% revenue growth is expected for the coming year 4.9%
- Share count grows by less than 3% a year -1.0%
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 28.9%
- Gross margin at 40% or higher and without meaningful erosion 42.3%
- Goodwill from acquisitions does not grow faster than revenue 41.5%
- Net debt below twice EBITDA 2.5 x EBITDA
- Operating cash flow covers the profits of the last three years 1,876 m
- Return on capital at 15% or higher, or up versus two years ago 16.5%
- Insiders hold at least 10% or are net buyers 0.1%
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Quality check
AAQS
9/10 Quality stockThe AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 8.3%
- Exp. sales growth 3Y > 5% 5.4%
- EBIT growth 10Y > 5% 11.0%
- Exp. EBIT growth 3Y > 5% 15.9%
- Net debt < 4x EBIT 3.0x
- EBIT positive, 10Y straight 10
- Max. EBIT decline < 50% 3.0%
- Return on equity > 15% –
- ROCE > 15% 16.5%
- Expected return > 10% 22.8%
View stocks with the full AAQS score · Read the methodology at AlleAktien
Source: fundamental data
Insiders
Insider Transactions
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Brennan Katherine | SVP and General Counsel | Sell | 1,197 | 187.90 | 224,915 |
| Sep 2, 2026 | Brennan Katherine | SVP and General Counsel | Other | 1,197 | 83.05 | 99,406 |
| Sep 2, 2026 | Doyle John Q | President and CEO | Sell | 16,656 | 188.51 | 3,139,823 |
| Sep 2, 2026 | Doyle John Q | President and CEO | Other | 16,656 | 73.20 | 1,219,136 |
| Aug 15, 2026 | Mills Steven A | Director | Other | 194 | 188.45 | 36,558 |
| Aug 15, 2026 | Broussard Bruce D | Director | Other | 192 | 188.45 | 36,181 |
| Aug 6, 2026 | Jones John Jude | Chief Marketing Officer | Sell | 6,500 | 191.96 | 1,247,723 |
| Jul 29, 2026 | Beswick Paul | SVP, Chief Information Officer | Sell | 713 | 198.00 | 141,174 |
| Jul 28, 2026 | South Martin | Chief Client Officer | Sell | 7,100 | 189.99 | 1,348,947 |
The company
About the Company
Marsh & McLennan Companies, Inc. ist ein professionelles Dienstleistungsunternehmen, das weltweit Beratungsdienste und Versicherungslösungen in den Bereichen Risiko, Strategie und Personal anbietet.
- Employees
- 95,000
- Headquarters
- New York, NY
- Address
- 1166 Avenue of the Americas, 10036-2774 New York, United States
- Phone
- 212-345-5000
- Website
- corporate.marsh.com
- IPO Date
- 12/30/1987
- ISIN
- US5717481023
- Stock Split
- 2:1 on 07/01/2002
- Stock Split
- 3:2 on 06/29/1998
- Stock Split
- 2:1 on 06/30/1997
Management
| Name | Title | Birth Year |
|---|---|---|
| John Quinlan Doyle | President, CEO & Director | 1964 |
| Mark Christopher McGivney | Executive VP, CFO & COO | 1968 |
| Martin C. South | Senior VP & Chief Client Officer | 1965 |
| Dean M. Klisura | Vice Chair, President & CEO of Marsh Re | 1964 |
| Patrick Tomlinson | Vice Chair, President & CEO of Marsh People and Investments | 1971 |
| Stacy M. Mills | VP, Controller & Chief Accounting Officer | 1965 |
| Paul Beswick | Senior VP and Global Chief Information & Operations Officer | 1975 |
| Jay H. Gelb C.F.A. | Head of Investor Relations of Marsh | – |
| Katherine J. Brennan | Senior VP & General Counsel | 1979 |
| John Jones | Senior VP and Chief Marketing & Communications Officer | 1972 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Filings
Company Filings (8-K)
An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).
- 07/21/2026 MARSH & MCLENNAN COMPANIES, INC. (MRSH): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.